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An isotopic reaction describes a novel cutaneous
condition occurring in a distribution previously
affected by another disease, a dermatologic example
of locus minoris resistentiae (LMR). LMR represents a
physiologic Achilles heel in the skin in which a
congenital or acquired altered defense capacity
causes a certain region of skin to be more vulnerable
and easily affected by a trigger or new disease than
others. Since its initial description in 1995, Wolf’s
isotopic reaction has been characterized as a type of
isotopic reaction in which a classically nondermato-
mal skin reaction presents in the same dermatome
after an initial pathologic insult of a herpes zoster
infection (or other herpes viruses).
Multiple cutaneous diseases are reported to arise
confined to dermatomes previously affected by these
viruses, including malignancies, fungal infections,
granulomatous diseases, and connective tissue dis-
eases.1 Hypotheses such as altered immune envi-
ronment, neuronal damage, and vulnerable
connective tissue have been implicated in the
development of this response. In vitro studies found
that varicella zoster virus alters gene expression
affecting cytokeratins, desmosomes, and proteases
in keratinocytes.2 In addition to keratinocytes, the
sensory nerve fibers, which modulate the skin im-
mune response secreting neuromediators such as
substance P, vasoactive intestinal peptide and calci-
tonin geneerelated peptide interact with membrane
receptors of immune cells in the skin.3 Immune
dysregulation is supported by comparative patch
testing studies in which skin previously affected by
herpes viruses responded differently compared with
unaffected skin when in contact with an allergen.4the Department of Dermatologya and Pathology Service,
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A 56-year-old white woman with a history of
systemic lupus erythematosus (SLE) diagnosed in her
20s and Sj€ogren’s disease, presented with a chief
complaint of a rash on her left leg and thigh, present
for 1 year. After a knee surgery 1 year before
presentation, the patient incurred a herpes zoster
infection on her left leg. The patient completed a
course of valacyclovir, and the rash resolved; how-
ever, the patient stated that the skin lesions for which
she presented developed in the same area months
later after clearance of her shingles infection. Review
of systemswas positive for joint pain, dry mouth, and
dry eyes. The patient’s medications included hydrox-
ychloroquine, 400 mg daily, for SLE and tramadol,
100 mg daily, for joint pain. A rheumatologist
managed the patient’s SLE until she presented, and
she never experienced any skinmanifestations of the
disease. Physical examination found numerous
blanching and nonblanching, faintly erythematous
to slightly violaceous, and salmon-colored macules
and thin scaly papules in a dermatomal configuration
on the anterior and lateral aspect of the left thigh
extending vertically down the left leg (Fig 1). No
vesicles or pustules were observed.
Laboratory results for antinuclear antibody;
anti-dsDNA; C-reactive protein; complement, rheu-
matoid factor, Ro, La, and Smith antibodies; and
anti-ribonucleoprotein were all within normal limitsJAAD Case Reports 2016;2:425-7.
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Fig 1. Cutaneous lupus in dermatomal distribution.
Erythematous papules in a dermatomal distribution along
the patient’s left lower extremity.
Fig 2. Cutaneous lupus. Biopsy of the left distal thigh
shows interface dermatitis, dyskeratosis, superficial peri-
vascular lymphocytic infiltrate, focal red blood cell extrav-
asation, and pigment incontinence.
Fig 3. Colloidal iron stain shows increased mucin.
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antinuclear antibody and other markers of autoim-
mune disease were positive at the time of diagnosis
and fluctuated over her 20-year course of disease. A
complete blood count showed mildly decreased
white blood cells and was otherwise was within
normal limits. Her anti-cyclic citrulinated peptide
was elevated. Two punch biopsies of affected skin
within the dermatomal band of lesions on the left
knee and left distal thigh were performed.
Histopathology of the tissue found interface
dermatitis with dyskeratosis, superficial perivascular
lymphocytic infiltrate, focal red blood cell
extravasation, and pigment incontinence (Fig 2).
No fungal organisms were identified on periodic
acideSchiff stain. Immunohistochemistry for herpes
simplex virus and varicella zoster virus were
negative. Neither vasculitis nor viral cytopathic
changes were seen. Colloidal iron stains showed
increased mucin (Fig 3). Clinical pathologic
correlation was consistent with the patient’s
underlying connective tissue disease.
The patient was prescribed triamcinolone to
affected areas, which did not improve her symptoms.
She was subsequently prescribed clobetasol to
affected areas twice daily, under occlusion, which
she found helpful. With continued use of clobetasol
ointment, the patient’s skin lesions began to fade
and transitioned from pink and erythematous
in color to hyperpigmented, with significantly
decreased pruritus.
DISCUSSION
Cases of systemic lupus erythematosus and
discoid lupus have been reported after herpes zoster
infections in a dermatomal distribution.5,6 Despite a
20-year history of systemic lupus, the only lupus-
related skin findings that the patient experienced
were nonphoto-exposed and within the dermatome
previously affected by zoster. She denied ever havinghad any other typical skin findings of photosensitive
dermatitis, such as a malar rash, at presentation. The
patient’s concomitant hydroxychloroquine therapy
may provide an explanation for lack of other
cutaneous lupus findings. Zoster infection, and
thus keratinocyte neuromediators and immune alter-
ation in the affected dermatome, could have pro-
duced a vulnerable cell line resistant to the patient’s
current dose of hydroxychloroquine. Lichen striatus
was also in the original differential, as both lupus and
lichen striatus have been reported to exhibit Wolf’s
isotype response after herpes zoster infection.3 The
presence of mucin on histopathologic analysis sup-
ported lupus as the pathology. Furthermore, the
bandlike pattern of the eruption was more consistent
with a dermatomal distribution rather than a thinly
whorled Blaschkoid distribution on the leg.7 The
occurrence of cutaneous lupus after a zoster infec-
tion and the dermatomal distribution of the eruption
support an isotopic reaction in this case. Thus,
remembering the old concept of locus minoris
resistentiae, a region of the skin that behaves as a
dermatologic Achilles heel, continues to inform our
understanding, workup, and diagnosis of dermato-
logic diseases that present in atypical distributions.
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